Research on New Strategies for Tumor Therapy Based on Nanostructured Materials
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 20 June 2024 | Viewed by 1916
Special Issue Editor
Special Issue Information
Dear Colleagues,
Despite being one of the most investigated diseases, cancer is still causing excessive burden that reaches much further than the affected person. Nanomaterial-based therapies, in addition to biological-based approaches, are one of the fastest developing new modalities to fight cancer. These efforts have already resulted in hundreds of new modalities based on unique and sometimes unexpected properties of nanomaterials. Being inorganic, organic, or biomaterial-based; "soft" or "hard"; with a core or hollow; and serving as either carriers of drugs, radioisotopes, or immune system triggers, these materials are proven to be capable of fighting cancers. However, this battle is far from over. Rather, it is just beginning. Relying on an endless pool of unique properties of nanomaterials, new modalities appear every day. In this Special Issue, we would like to shed light on the recent status and offer a glimpse of the future perspective of fighting cancer using the unique properties of nanomaterials.
I look forward to receiving your contributions.
Dr. Željko Prijović
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- tumor
- nanomaterial-based therapies
- nanomaterials
- nanostructured